UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1.
Full Text
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature genetics, ISSN 1061-4036, 02/2019, Volume 51, Issue 2, pp. 202 - 206
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Immunotherapy - methods | Neoplasms - therapy | Neoplasms - genetics | Antineoplastic Agents - immunology | Neoplasms - immunology | Humans | Tumor Burden - genetics | High-Throughput Nucleotide Sequencing - methods | Mutation - genetics | Tumor Burden - immunology | Usage | Research | Gene mutations | Immunotherapy | Oncology, Experimental | Cancer | Laboratories | Lung cancer | Melanoma | Histology | Metastasis | Gene expression | Cancer therapies | Patients | Survival | Metastases | Next-generation sequencing | Immune checkpoint | Biomarkers | Mutation | Tumors | Index Medicus
Journal Article
Nature reviews. Cancer, ISSN 1474-175X, 10/2012, Volume 12, Issue 10, pp. 671 - 684
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematopoietic Stem Cells - immunology | Neoplasms - therapy | Signal Transduction | Neoplasms - immunology | Humans | Hematopoietic Stem Cell Transplantation | Immunologic Memory | T-Lymphocytes - immunology | Cell Differentiation | Adoptive Transfer | T-Lymphocytes - transplantation | Care and treatment | Stem cells | Cellular therapy | Research | Properties | T cells | Health aspects | Tumors | Index Medicus
Journal Article
Nature medicine, ISSN 1078-8956, 01/2016, Volume 22, Issue 1, pp. 26 - 36
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Genetic Engineering - methods | Immunotherapy, Adoptive - methods | Neoplasms - therapy | T-Lymphocytes | Antigens, Neoplasm - immunology | Neoplasms - immunology | Humans | Receptors, Antigen, T-Cell - immunology | Receptors, Antigen, T-Cell - genetics | Adoptive Transfer | Care and treatment | Immunotherapy | Physiological aspects | Genetic aspects | Research | T cells | Methods | Tumors | Antigens | Genetic engineering | T cell receptors | Mutation | Cancer | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 01/2016, Volume 126, Issue 1, pp. 318 - 334
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunotherapy, Adoptive | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Proto-Oncogene Proteins c-akt - physiology | Fas Ligand Protein - physiology | Animals | T-Lymphocytes - cytology | Female | Immunologic Memory | T-Lymphocytes - immunology | Cell Differentiation | Mice | fas Receptor - physiology | Genetic aspects | Research | Cell differentiation | Immunotherapy | Cells | T cells | Health aspects | Antigens | Medical research | Flow cytometry | Clinical trials | T cell receptors | Genomes | Kinases | Gene expression | Experiments | Patients | Lymphocytes | Population | Software | Charitable foundations | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
5.
Full Text
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
Immunological reviews, ISSN 0105-2896, 07/2019, Volume 290, Issue 1, pp. 127 - 147
TCR mimic | ImmTAC | CRISPR/Cas9 | adoptive immunotherapy | genetic engineering | Life Sciences & Biomedicine | Immunology | Science & Technology | Immunotherapy, Adoptive - adverse effects | Neoplasms - metabolism | Immunotherapy, Adoptive - methods | Receptors, Antigen, T-Cell - metabolism | Antigens, Neoplasm - immunology | Humans | Treatment Outcome | Clinical Studies as Topic | Neoplasms - therapy | Animals | Genetic Engineering | T-Lymphocytes - metabolism | Neoplasms - immunology | Receptors, Chimeric Antigen - genetics | T-Cell Antigen Receptor Specificity | T-Lymphocytes - immunology | Receptors, Antigen, T-Cell - genetics | Receptors, Chimeric Antigen - metabolism | Care and treatment | Immunotherapy | Genetically modified organisms | Genetic engineering | Drug therapy | T cells | Cancer | Antigenic determinants | Antigens | Innovations | Clinical trials | Universe | T cell receptors | Genomes | Lymphocytes T | Epitopes | T-cell receptor | Chimeric antigen receptors | Receptors | Immune checkpoint | Lymphocytes | Recognition | Cytoplasm | Index Medicus | CRISPR | Invited Reviews | Cas9 | Invited Review
Journal Article